%0 Journal Article
%T Viral Metagenomics of Blood Donors and Blood-Derived Products Using Next-Generation Sequencing
%A Marco Alessandrini
%A Olivier Preynat-Seauve
%A Sofiane Taleb
%A Sophie Waldvogel-Abramowski
%J Archive of "Transfusion Medicine and Hemotherapy".
%D 2019
%R 10.1159/000499088
%X Transfusion-transmitted infections remain a permanent threat in medicine. It keeps the burden of the past, marked by serious infections transmitted by transfusion, and is constantly threatened by emerging viruses. The global rise of immunosuppression among patients undergoing frequent transfusions exacerbates this problem. Over the past decade, criteria for donor selection have become increasingly more stringent. Although routine nucleic acid testing (NAT) for virus-specific detection has become more sensitive, these safety measures are only valuable for a limited number of select viruses. The scientific approach to this is however changing, with the goal of trying to identify infectious agents in donor units as early as possible to mitigate the risk of a clinically relevant infection. To this end, and in addition to an epidemiological surveillance of the general population, researchers are adopting new methods to discover emerging infectious agents, while simultaneously screening for an extended number of viruses in donors. Next-generation sequencing (NGS) offers the opportunity to explore the entire viral landscape in blood donors, the so-called metagenomics, to investigate severe transfusion reactions of unknown etiology. In the not too distant future, one could imagine this platform being used for routine testing of donated blood products
%K Blood products
%K Transfusion-associated infections
%K Virus safety
%K Metagenomics
%K Next-generation sequencing
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514509/